Marcantonio L A, Auld W H, Skellern G G, Howes C A, Murdoch W R, Purohit R
J Pharmacokinet Biopharm. 1982 Aug;10(4):393-409. doi: 10.1007/BF01065171.
The pharmacokinetics and pharmacodynamics of bumetanide (1 mg) administered either orally or intravenously were studied in a group of normal subjects using high-pressure liquid chromatography. A two-compartment model adequately fitted the intravenous data. Renal clearance (85 ml min-1) contributed 65% to the total elimination of bumetanide irrespective of whether a model-dependent or model-independent method was used. Oral administration of bumetanide elicited a greater and a more prolonged pharmacological response than did intravenous bumetanide. An attempt is made to relate the pharmacokinetics of the drug to its pharmacodynamics.
在一组正常受试者中,使用高压液相色谱法研究了口服或静脉注射布美他尼(1毫克)的药代动力学和药效学。二室模型能很好地拟合静脉注射数据。无论采用模型依赖法还是模型非依赖法,肾清除率(85毫升/分钟)对布美他尼总清除率的贡献率均为65%。与静脉注射布美他尼相比,口服布美他尼引起的药理反应更强且更持久。本文尝试将该药物的药代动力学与其药效学联系起来。